Literature DB >> 2970354

The influence of the normal microbial flora on the susceptibility of rats to experimental autoimmune thyroiditis.

W J Penhale1, P R Young.   

Abstract

Female PVG/c strain rats maintained under specific pathogen-free conditions until weaning were found to be significantly less susceptible to the induction of autoimmune thyroiditis by thymectomy and irradiation than conventionally reared rats of the same strain. Other SPF-derived strains had a similarly low susceptibility, thus pointing to an important external factor influencing the induction of autoimmunity by this procedure. It was found that the oral administration of antibiotics followed by fresh, homogenized, intestinal contents obtained from conventionally reared rats to newly weaned SPF PVG/c rats significantly augmented their autoimmune susceptibility. The offspring of female SPF rats which had been treated in late pregnancy with oral antibiotics and conventional intestinal contents were similarly more susceptible than the offspring of non-treated counterparts. It is proposed that the composition of the normal gastrointestinal flora of conventionally reared rats profoundly influences susceptibility to the induction of autoimmune thyroiditis in this particular experimental model, possibly by antigenic cross-reactivity with thyroid tissue.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970354      PMCID: PMC1541533     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  An immunological cross-reaction between group-A streptococcal cells and human heart tissue.

Authors:  M H KAPLAN; M MEYESERIAN
Journal:  Lancet       Date:  1962-04-07       Impact factor: 79.321

2.  Production of choriogonadotropin-like factor by a microorganism.

Authors:  T Maruo; H Cohen; S J Segal; S S Koide
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

3.  Spontaneous thyroiditis in thymectomized and irradiated Wistar rats.

Authors:  W J Penhale; A Farmer; R P McKenna; W J Irvine
Journal:  Clin Exp Immunol       Date:  1973-10       Impact factor: 4.330

4.  Reconventionalization following antibiotic decontamination in man and animals.

Authors:  D van der Waaij; J M Vossen; C K Altes; C Hartgrink
Journal:  Am J Clin Nutr       Date:  1977-11       Impact factor: 7.045

5.  Antibodies to Yersinia enterocolitica in thyroid disease.

Authors:  L Shenkman; E J Bottone
Journal:  Ann Intern Med       Date:  1976-12       Impact factor: 25.391

6.  Ankylosing spondylitis, immune-response-genes and molecular mimicry.

Authors:  A Ebringer
Journal:  Lancet       Date:  1979-06-02       Impact factor: 79.321

7.  Thyroiditis in T cell-depleted rats: suppression of the autoallergic response by reconstitution with normal lymphoid cells.

Authors:  W J Penhale; W J Irvine; J R Inglis; A Farmer
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

8.  IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides.

Authors:  S Izui; R A Eisenberg; F J Dixon
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

9.  Indirect immunofluorescence staining of human thyroid by antibodies occurring in Yersinia enterocolitica infections.

Authors:  K Lidman; U Eriksson; R Norberg; A Fagraeus
Journal:  Clin Exp Immunol       Date:  1976-03       Impact factor: 4.330

10.  Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide.

Authors:  P S Esquivel; N R Rose; Y C Kong
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more
  22 in total

Review 1.  Are the inflammatory bowel diseases autoimmune disorders?

Authors:  J Snook
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

2.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

Review 3.  Modulation of autoimmune arthritis by environmental 'hygiene' and commensal microbiota.

Authors:  David Langan; Eugene Y Kim; Kamal D Moudgil
Journal:  Cell Immunol       Date:  2018-12-10       Impact factor: 4.868

Review 4.  Does the microbiota play a role in the pathogenesis of autoimmune diseases?

Authors:  Mairi H McLean; Dario Dieguez; Lindsey M Miller; Howard A Young
Journal:  Gut       Date:  2014-11-21       Impact factor: 23.059

5.  Distinct genetic pattern of mouse susceptibility to thyroiditis induced by a novel thyroglobulin peptide.

Authors:  G Carayanniotis; E Chronopoulou; V P Rao
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  Host-microflora interaction in systemic lupus erythematosus (SLE): colonization resistance of the indigenous bacteria of the intestinal tract.

Authors:  H Z Apperloo-Renkema; H Bootsma; B I Mulder; C G Kallenberg; D van der Waaij
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

Review 7.  Infection and autoimmunity: Lessons of animal models.

Authors:  M Pásztói; P Misják; B György; B Aradi; T G Szabó; B Szántó; M Cs Holub; Gy Nagy; A Falus; E I Buzás
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-09-09

Review 8.  Autoantigens in thyroid diseases.

Authors:  K Dawe; P Hutchings; B Champion; A Cooke; I Roitt
Journal:  Springer Semin Immunopathol       Date:  1993

Review 9.  Gut microbiota and Hashimoto's thyroiditis.

Authors:  Camilla Virili; Poupak Fallahi; Alessandro Antonelli; Salvatore Benvenga; Marco Centanni
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

10.  Host-microflora interaction in systemic lupus erythematosus (SLE): circulating antibodies to the indigenous bacteria of the intestinal tract.

Authors:  H Z Apperloo-Renkema; H Bootsma; B I Mulder; C G Kallenberg; D van der Waaij
Journal:  Epidemiol Infect       Date:  1995-02       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.